Package 42364-0011-1

{"route": ["ORAL"], "spl_id": "07ad62bb-147a-4760-9723-81334658bb9c", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["243694", "1101754"], "spl_set_id": ["f879e8c7-1983-4a85-b87d-38f5068351fc"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["DSE Healthcare Solutions, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (42364-0011-1)  / 100 TABLET, COATED in 1 BOTTLE", "package_ndc": "42364-0011-1", "marketing_end_date": "20260831", "marketing_start_date": "20180715"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (42364-0011-2)  / 120 TABLET, COATED in 1 BOTTLE", "package_ndc": "42364-0011-2", "marketing_end_date": "20260831", "marketing_start_date": "20180715"}], "brand_name": "vanquish", "product_id": "42364-0011_07ad62bb-147a-4760-9723-81334658bb9c", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "42364-0011", "generic_name": "acetaminophen, aspirin, and caffeine", "labeler_name": "DSE Healthcare Solutions, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "vanquish", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "194 mg/1"}, {"name": "ASPIRIN", "strength": "227 mg/1"}, {"name": "CAFFEINE", "strength": "33 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20260831", "marketing_start_date": "20180715"}